In addition to suppressing breast cancer cell viability,7, 8, 42 reprograming of MET, a hallmark of reversing cancer stemness mechanism,43 is also known to be regulated by CCN5 through TGF‐β‐mediated signaling.9, 13. This evidence concerns the gene CCN5 and breast carcinoma.